🇺🇸 FDA
Pipeline program

INZ-701

INZ701-104

Phase 3 small_molecule active

Quick answer

INZ-701 for Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency is a Phase 3 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 2 ClinicalTrials.gov record(s).

Program details

Company
BIOMARIN PHARMACEUTICAL INC
Indication
Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials